Pharming Group N.V. ADS (PHAR)
NGM · ADR · CUSIP 71716E105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PHAR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
71716E105
Market Cap
Mid Cap · $730 Million
IPO
12/23/2020 · $17.86/share
ADR Ratio
1:10
Business: Pharming Group N.V. is a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs.

Company Contact

CEO
Sijmen de Vries
CFO
Jeroen Wakkerman
Investor Relations
investor@pharming.com
SEC EDGAR Filings
View filings »